Kalia Kumud, Chief Information Officer, has demonstrated a clear selling bias in their recent insider trading activity, as evidenced by SEC Form 4 filings. Over the course of 32 transactions, Kumud has sold shares totaling $6,168,864.07 while purchasing shares worth $1,330,016.80, reflecting a significant net outflow. All transactions have been concentrated in a single company, Guardant Health, Inc. (ticker: GH), indicating a focused investment strategy tied to this entity.
Recent filings highlight a continued trend of divestment. On March 4, 2026, Kumud executed two substantial sales, totaling $3,812,660.54, alongside smaller transactions related to derivative securities. This was followed by another sale on March 15, 2026, valued at $584,666.11. Notably, Kumud has not made any recent purchases, with the last buy occurring in 2025. The pattern suggests a deliberate reduction in holdings, particularly as the majority of transactions in 2026 have been sales or derivative-related adjustments.
While the reasons behind these transactions are not disclosed, the data underscores a consistent shift away from equity accumulation in GH. This activity aligns with Kumud’s broader trading history, which has been predominantly characterized by selling since 2025. The absence of recent buys further reinforces this trend, positioning Kumud as a net seller in their insider trading activity.
AI-assisted summary